Callan Family Office’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
VCM
NC
VPM
Callan Family Office's SNPS Position: Q1 2026 in Review
Callan Family Office increased its Synopsys (SNPS) stake by 6.6% in Q1 2026, buying an estimated $160K and bringing the position to 5,706 shares worth $2.26M. The position accounts for 0.05% of the portfolio, ranked #321.
Callan Family Office first reported a position in SNPS in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.51M in Q4 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.
- Callan Family Office held 5,706 shares of Synopsys worth $2.26M as of Q1 2026.
- Callan Family Office bought 354 Synopsys shares in Q1 2026, an estimated $160K.
- Synopsys made up 0.05% of Callan Family Office's portfolio in Q1 2026, its #321 holding.
- Callan Family Office first reported a position in Synopsys in Q4 2024 and has held it in 6 quarters since.
- Callan Family Office's Synopsys position peaked at $2.51M in Q4 2025.
- 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.